about
New drugs and treatment targets in psoriasisOptimizing diagnostic tests for persulphate-induced respiratory diseasesDistinguishing hyperhidrosis and normal physiological sweat production: new data and review of hyperhidrosis data for 1980-2013.Oral symptoms and salivary findings in oral lichen planus, oral lichenoid lesions and stomatitis.Pulsed dye laser vs. intense pulsed light for port-wine stains: a randomized side-by-side trial with blinded response evaluation.Occupational contact dermatitis in painters: an analysis of patch test data from the Danish Contact Dermatitis Group.Trends and developments in the pharmacological treatment of psoriasis.Properties of the novel proinflammatory supergene "intercrine" cytokine family.Irritant contact dermatitis from shower cream applied as a moisturizing cream: a review of three cases*.Systemic combination treatment for psoriasis: a review.A reduced national incidence of anogenital warts in young Danish men and women after introduction of a national quadrivalent human papillomavirus vaccination programme for young women--an ecological study.A comprehensive pathophysiology of dandruff and seborrheic dermatitis - towards a more precise definition of scalp health.Ixekizumab for treatment of psoriasis.Prevalence and cause of methylisothiazolinone contact allergy.Effect of weight loss on the severity of psoriasis: a randomized clinical study.Chromium allergy and dermatitis: prevalence and main findings.Targeting IL-17 with ixekizumab in patients with psoriasis.Biosimilars for Psoriasis: Worldwide Overview of Regulatory Guidelines, Uptake and Implications for Dermatology Clinical Practice.Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management.Biosimilars for psoriasis: clinical studies to determine similarity.Contact Allergy in Danish Healthcare Workers: A Retrospective Matched Case-control Study.Prevalence of atopic dermatitis in infants by domestic water hardness and season of birth: Cohort study.Characteristics of chromium-allergic dermatitis patients prior to regulatory intervention for chromium in leather: a questionnaire study.Trends in contact allergy to fragrance mix I in consecutive Danish patients with eczema from 1986 to 2015: a cross-sectional study.Management of Atopic Hand Dermatitis.Cross-reactivity between methylisothiazolinone, octylisothiazolinone and benzisothiazolinone using a modified local lymph node assay.Cardiovascular risk factors in subjects with psoriasis: a cross-sectional general population study.Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.Incidence of skin and respiratory diseases among Danish hairdressing apprentices.Contact allergy to chlorhexidine in a tertiary dermatology clinic in Denmark.Consumer leather exposure: an unrecognized cause of cobalt sensitization.Increased expression of glucagon-like peptide-1 receptors in psoriasis plaques.Gabapentin-induced bullous pemphigoid.Methyldibromo glutaronitrile: clinical experience and exposure-based risk assessment.Psoriasis and the Framingham risk score in a Danish hospital cohort.The outcome of dimethylglyoxime testing in a sample of cell phones in Denmark.Unusual presentation of ORF in an otherwise healthy individual.Experimental elicitation of contact allergy from a diazolidinyl urea-preserved cream in relation to anatomical region, exposure time and concentration.Xerosis is associated with atopic dermatitis, hand eczema and contact sensitization independent of filaggrin gene mutations.ROAT: morphology of ROAT on arm, neck and face in formaldehyde and diazolidinyl urea sensitive individuals.
P50
Q27009742-547C7C53-1F98-4735-8C75-DAA1FE80F195Q30378337-19876CC5-CCE3-4E9D-A093-7BF6BCBBD504Q30884919-BD583389-F958-4DAF-8CC5-3B8B9F941605Q32175992-EE664485-BB30-41DD-9F8F-C57C9064E656Q33397072-7EB88D8C-A4D5-4074-B348-5A8CB68E1603Q34253782-9267DD6C-3412-4F00-88C9-8096FB4E9D40Q35063111-61DA0124-F12A-41DE-9D1C-5F34474142ECQ37357898-CA266DE1-5375-4E77-BC15-C60469729161Q37603387-F65B6705-C535-42E6-B8ED-BDE7A50B54A6Q37767360-2E6C18CE-29A7-4BCF-9DD1-452193705CFAQ37845640-5138928C-996C-411C-AFD3-64AAE75204C3Q38033047-69B3CCD0-977D-4522-A353-BEB0F4BDCC93Q38369782-686CFA91-FF11-420F-8132-B36B0D1650C4Q38443529-4EB42499-6FDB-49E3-AF0C-FB57E8BA0257Q38450207-0D877C03-8D8D-4BA4-9A8F-4C456EA75B62Q38536207-088BF8AD-1481-4745-BDDD-EF722587758EQ38633741-EA9115A5-E24D-4068-84FA-463F9080E68EQ38667296-726DC9F9-315A-461F-A14F-678DD03161A8Q38942472-37D5689C-F8F0-42A3-8018-C06C99F41208Q38957406-19A2F915-E9A2-456B-8FFC-7743779E7854Q38975800-8E00D223-7702-47F4-A1C1-E0E436AC87EAQ39065401-A3BA210E-4640-4D7F-A4A5-552AE38E9E77Q39142299-499C3344-07C7-4D74-B85B-C22FCB01B036Q39175793-26FF8BDD-75F7-45A1-BB55-AB28AC6A175BQ39348252-DE4271CA-72D9-4899-BAF8-08691C2FC2EBQ39655490-4332C44C-56C3-42BE-ABDB-94D079A21061Q40031011-6091D7C6-B2DF-4CEF-A345-99D668E7679FQ40048725-DADC90A6-13DE-4BE7-9151-934B96F3CAC9Q40379718-E205CE44-17D0-4A4B-A7C8-2006EAC23CCCQ41130005-C67893D1-2636-4651-92A9-4D0C4BC2E3A7Q44065821-6EE0DD13-AED5-496E-9BC2-C7000EF15E30Q44120881-0BFE1AF4-F5A8-478A-833C-1F8CE42E9CD1Q44215697-45FA6BD1-ACFB-48E8-9383-7C9AD30AA510Q44446854-CFCD3E20-5AD3-4DCC-A26C-147174E8E031Q45717444-D1643651-FFC0-4088-88BF-E6EB561E2551Q46552913-133F3717-3908-49D0-8B16-A13F6B28FA9CQ46595190-6FA90352-EFB1-4FA6-9D7D-45C6D2367B33Q46800918-69EAED41-7FB4-434C-8B88-354E61569909Q46868676-BA7B5A2C-417B-4D58-8A83-EADAEA8F1E60Q46903601-DFB6F178-AA06-46D0-A872-F37B1706A006
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Claus Zachariae
@ast
Claus Zachariae
@en
Claus Zachariae
@es
Claus Zachariae
@nl
Claus Zachariae
@sl
type
label
Claus Zachariae
@ast
Claus Zachariae
@en
Claus Zachariae
@es
Claus Zachariae
@nl
Claus Zachariae
@sl
prefLabel
Claus Zachariae
@ast
Claus Zachariae
@en
Claus Zachariae
@es
Claus Zachariae
@nl
Claus Zachariae
@sl
P1053
G-6144-2018
P106
P214
404152636171120052662
P31
P3829
P496
0000-0001-5506-1319
P735
P7859
viaf-404152636171120052662